Fidelity Advisor Freedom 2020 Fund - Class A
FDAFX
NASDAQ
| Weiss Ratings | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Fidelity Investments | |||
| Manager/Tenure (Years) | Andrew J Dierdorf (13), Brett F. Sumsion (11), Cait Dourney (0), 1 other | |||
| Website | http://www.institutional.fidelity.com | |||
| Fund Information | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Fidelity Advisor Freedom 2020 Fund - Class A | |||
| Category | Target-Date 2020 | |||
| Sub-Category | Target Date | |||
| Prospectus Objective | Asset Allocation | |||
| Inception Date | Jul 24, 2003 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.26% | |||
| Dividend | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.14% | |||
| Asset Allocation | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | -0.60% | |||
| Stock | 47.12% | |||
| U.S. Stock | 23.34% | |||
| Non-U.S. Stock | 23.78% | |||
| Bond | 53.00% | |||
| U.S. Bond | 45.59% | |||
| Non-U.S. Bond | 7.41% | |||
| Preferred | 0.05% | |||
| Convertible | 0.01% | |||
| Other Net | 0.43% | |||
| Price History | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.01% | |||
| 30-Day Total Return | 1.89% | |||
| 60-Day Total Return | 4.03% | |||
| 90-Day Total Return | 2.56% | |||
| Year to Date Total Return | 5.10% | |||
| 1-Year Total Return | 7.96% | |||
| 2-Year Total Return | 19.05% | |||
| 3-Year Total Return | 18.48% | |||
| 5-Year Total Return | 31.50% | |||
| Price | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $11.94 | |||
| 1-Month Low NAV | $11.70 | |||
| 1-Month High NAV | $12.09 | |||
| 52-Week Low NAV | $11.30 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $12.54 | |||
| 52-Week High Price (Date) | Dec 06, 2024 | |||
| Beta / Standard Deviation | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.34 | |||
| Standard Deviation | 11.27 | |||
| Balance Sheet | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.10B | |||
| Operating Ratios | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.80% | |||
| Turnover Ratio | 17.00% | |||
| Performance | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 9.12% | |||
| Last Bear Market Total Return | -10.81% | |||